These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity. Murphy CS, Parker CJ, McCague R, Jordan VC. Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879 [Abstract] [Full Text] [Related]
6. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma. Kawamura I, Mizota T, Mukumoto S, Manda T, Masuda K, Nakamura T, Kubota H, Matsumoto S, Nishigaki F, Shimomura K. Arzneimittelforschung; 1989 Aug; 39(8):889-93. PubMed ID: 2818677 [Abstract] [Full Text] [Related]
7. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells. Kawamura I, Lacey E, Mizota T, Tsujimoto S, Nishigaki F, Manda T, Shimomura K. Anticancer Res; 1994 Aug; 14(2A):427-31. PubMed ID: 8017842 [Abstract] [Full Text] [Related]
8. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA, Lippman ME, Katzenellenbogen BS. Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [Abstract] [Full Text] [Related]
11. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830 [Abstract] [Full Text] [Related]
12. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites. Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL. Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885 [Abstract] [Full Text] [Related]
13. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Kawamura I, Mizota T, Kondo N, Shimomura K, Kohsaka M. Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300 [Abstract] [Full Text] [Related]
16. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M. Cancer Res; 1999 Aug 01; 59(15):3646-51. PubMed ID: 10446976 [Abstract] [Full Text] [Related]
17. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC. Clin Cancer Res; 2002 Jun 01; 8(6):1995-2001. PubMed ID: 12060645 [Abstract] [Full Text] [Related]
19. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Wang Z, Kyo S, Maida Y, Takakura M, Tanaka M, Yatabe N, Kanaya T, Nakamura M, Koike K, Hisamoto K, Ohmichi M, Inoue M. Oncogene; 2002 May 16; 21(22):3517-24. PubMed ID: 12032853 [Abstract] [Full Text] [Related]
20. Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells. Benz C, Santos GF. Mol Pharmacol; 1987 Jul 16; 32(1):13-6. PubMed ID: 3600613 [Abstract] [Full Text] [Related] Page: [Next] [New Search]